论文部分内容阅读
[目的]探讨厄贝沙坦氢氯噻嗪片治疗轻中度高血压病患者的疗效.[方法]将136例轻中度高血压病患者随机分为两组,观察组(68例)服用厄贝沙坦氢氯噻嗪片治疗,对照组(68例)服用厄贝沙坦片治疗,均治疗8周,对比分析两组患者的疗效及不良反应.[结果]观察组总有效率为97.1%,明显高于对照组的77.9%,差异有显著性( P 0.05).[结论]厄贝沙坦氢氯噻嗪片治疗轻中度高血压病患者具有疗效确切、不良反应发生率低等优点.“,”Objective] To explore the clinical efficacy of irbesartan hydrochlorothiazide tablets for the treatment of patients with mild‐to‐moderate hypertension .[Methods] Totally 136 patients with mild‐to‐moderate hypertension were divided into 2 groups randomly .The observation group ( n = 68) received irbesartan hydrochlorothiazide tablets ,while control group( n = 68) was given irbesartan hydrochlorothiazide tablets .All patients were treated for 8 weeks .The effi‐cacy and incidence rate of adverse reactions were compared between two groups .[Results] The total effective rate in ob‐servation group was 97 .1% ,which was obviously higher that in control group ,and there was significant difference ( P 0 .05) .[Conclusion] Irbesartan hydrochlorothiazide tablets for the treatment of patients with mild‐to‐moderate hypertension has advantages such as certain efficacy and low incidence rate of adverse reactions .